Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows used in operating activities:    
Net income (loss) from continuing operations $ (3,965,798) $ (28,419,936)
Adjustments to reconcile net income (loss) to net cash used in operations:    
Depreciation and amortization 804,074 1,273,435
Gain on sale of fixed assets (549,524)
Stock issued for services 161,003
Stock-based compensation 739,729 34,081
Non-cash interest expense 8,441,043
Amortization of debt discount 16,080,270 6,228,352
Gain on purchase of Jamestown Medical Center (7,732,302)
Non-cash settlement of debt (50,000)
Gain on extinguishment of debt (42,702,815)
Change in fair value of derivative instruments (13,688,678) 42,702,815
Income (loss) from discontinued operations 115,787 (2,752,173)
Changes in operating assets and liabilities:    
Accounts receivable (5,648,343) 828,450
Inventory 25,066 (73,732)
Prepaid expenses and other current assets 85,185 6,592
Security deposits 27,857 (14,559)
Accounts payable 3,497,210 1,378,419
Accrued expenses 3,728,038 2,067,818
Income tax assets and liabilities (12,243) (451,997)
Net cash used in operating activities of continuing operations (6,493,672) (11,343,204)
Net cash used in discontinued operations (628,154) (449,925)
Net cash used in operating activities (7,121,826) (11,793,129)
Cash flows provided by (used in) investing activities:    
Purchase of Jamestown Regional Medical Center, net of cash acquired (668,983)
Sale of property and equipment 433,612
Purchase of property and equipment (103,387) (1,554,499)
Net cash used in investing activities of continuing operations (338,758) (1,554,499)
Net cash provided by investing activities of discontinued operations 800,000 1,936
Net cash provided by (used in) investing activities 461,242 (1,552,563)
Cash flows provided by financing activities:    
Proceeds from issuance of related party notes payable and advances 3,805,000
Proceeds from issuance of debentures 8,000,000 15,742,500
Payments on related party notes payable and advances (428,500) (3,860,000)
Payments on notes payable (256,481) (1,042,524)
Payments on capital lease obligations (654,435) (1,342,970)
Net cash provided by financing activities of continuing operations 6,660,584 13,302,006
Net cash used in financing activities of discontinued operations
Net cash provided by financing activities 6,660,584 13,302,006
Net increase (decrease) in cash (43,686)
Cash at beginning of period 70,173
Cash at end of period $ 26,487